Eyenovia Announces FDA Acceptance of IND Application for MicroPine to Reduce the Progression of Myopia
Longevity Investing Evolus Phase III European – Canadian Head-to-Head Trial of prabotulinumtoxinA Compared to Botox® Meets Primary Endpoint
Soleno Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2017 Financial Results
Pharmaceutical Investing ChemoCentryx Reports Fourth Quarter and Full Year 2017 Financial Results and Recent Highlights
Gold Investing Newrange Gold Samples Up To 130 Grams Gold, Extends Merritt Zone And Begins Phase III Drilling At Pamlico
Pharmaceutical Investing Novartis receives FDA approval for Cosentyx label update to include moderate-to-severe scalp psoriasis
Market News Newrange Gold Reports Last Drill Results for 2017 and Start of 2018 Drilling At Pamlico Gold Project, Nevada
Juggernaut Announces Strategic Investment by Crescat Capital Funds for 28.95% Ownership - Dr. Quinton Hennigh Technical Advisor
